Recommended Dosages and Clinical Uses of Progesterone
For prevention of preterm birth and endometrial protection, progesterone should be administered at specific evidence-based dosages tailored to the clinical indication, with 17P 250 mg IM weekly for prior preterm birth and vaginal progesterone 90-200 mg daily for short cervix. 1, 2
Preterm Birth Prevention
Singleton Pregnancies with Prior Spontaneous Preterm Birth (SPTB)
- 17-alpha-hydroxyprogesterone caproate (17P): 250 mg intramuscularly weekly
Singleton Pregnancies with Short Cervical Length (No Prior SPTB)
- Vaginal progesterone: Either 90 mg gel or 200 mg suppository daily
- Start: At diagnosis of short cervix (≤20 mm on transvaginal ultrasound at ~24 weeks)
- Continue until: 36 weeks gestation
- Reduces preterm birth rates by 45% and composite neonatal morbidity/mortality by 43% 1
Management Algorithm for Preterm Birth Prevention
- For women with prior SPTB: Start 17P at 16-20 weeks
- For women without prior SPTB but short cervix ≤20 mm: Start vaginal progesterone
- For women with prior SPTB who develop short cervix <25 mm while on 17P: Continue 17P (insufficient evidence to switch therapies) 1
Populations NOT Benefiting from Progesterone for Preterm Birth Prevention
- Multiple gestations (twins, triplets) without other risk factors
- Preterm labor (for tocolysis)
- Preterm premature rupture of membranes (PPROM)
- Singleton pregnancies without prior SPTB or short cervix 1, 2
Hormone Replacement Therapy
Prevention of Endometrial Hyperplasia
- Oral micronized progesterone: 200 mg daily
- Administration: At bedtime for 12 continuous days per 28-day cycle
- Used in postmenopausal women with intact uterus who are receiving estrogen therapy
- Reduces risk of endometrial hyperplasia from 64% (estrogen alone) to 6% (with progesterone) 3
Secondary Amenorrhea
- Oral micronized progesterone: 400 mg daily
Premature Ovarian Insufficiency (POI)
- Begin cyclic progestogens after at least 2 years of estrogen therapy or when breakthrough bleeding occurs 1
- For adolescents with POI (e.g., Turner Syndrome):
- Start progestogen after 2 years of estrogen or when breakthrough bleeding occurs
- Oral micronized progesterone: 100-200 mg/day or dydrogesterone 5-10 mg/day during 12-14 days of the month 1
Administration Considerations
- Oral progesterone: Take at bedtime with a glass of water while standing to minimize difficulty swallowing and reduce drowsiness side effects 3
- Vaginal progesterone: Available as gel or suppository formulations, allowing for self-administration with fewer systemic side effects 2
- 17P: Requires weekly office visits for intramuscular injection, may cause local injection site pain 2
Common Side Effects and Precautions
- Oral progesterone: Drowsiness, dizziness, headaches, breast pain, irregular vaginal bleeding, abdominal cramps, nausea 3
- Contraindications: Unusual vaginal bleeding, certain cancers, history of stroke/heart attack, blood clots, liver problems, peanut allergy (oral formulation contains peanut oil) 3
Clinical Pearls
- When using progesterone for endometrial protection, the minimum effective dose should be prescribed to reduce side effects 4
- For postmenopausal women, continuous daily progestin maintains the endometrium in an inactive phase in 100% of women, while cyclic progestin achieves this in only 25% 5
- Vaginal progesterone achieves higher uterine concentrations despite lower systemic levels due to direct vagina-to-uterus transport 6
- For prevention of miscarriage, progesterone may benefit women with previous miscarriages and current pregnancy bleeding, but is not recommended for the general population 2
- Take oral progesterone at bedtime to minimize drowsiness side effects 7
By following these evidence-based recommendations for progesterone dosing and administration, clinicians can optimize outcomes while minimizing side effects across various clinical indications.